Vivo Bio Tech (BOM:511509) 3-Year Revenue Growth Rate : -10.70% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Vivo Bio Tech 3-Year Revenue Growth Rate?

Vivo Bio Tech's Revenue per Share for the three months ended in Mar. 2024 was ₹5.30.

During the past 12 months, Vivo Bio Tech's average Revenue per Share Growth Rate was -22.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was -10.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was -10.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Vivo Bio Tech was 35.90% per year. The lowest was -11.10% per year. And the median was 10.00% per year.

Competitive Comparison of Vivo Bio Tech's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Vivo Bio Tech's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivo Bio Tech's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Vivo Bio Tech's 3-Year Revenue Growth Rate falls into.

Vivo Bio Tech 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Vivo Bio Tech (BOM:511509) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Vivo Bio Tech 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Vivo Bio Tech's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivo Bio Tech (BOM:511509) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivo Bio Tech Ltd (BOM:511509) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 8-2-672/ 5 and 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034

Website

http://www.vivobio.com

Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.

Vivo Bio Tech (BOM:511509) Headlines

No Headlines